Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Bregua Corporation

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$52M
Portfolio companies 5
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.29
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Health Diagnostics
  • Pharmaceutical
Summary

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Bregua Corporation, startups are often financed by Avalon Ventures, Torrey Pines Investment, WuXi Healthcare Ventures. The meaningful sponsors for the fund in investment in the same round are Avalon Ventures, WuXi Healthcare Ventures, Vivo Capital.

Among the various public portfolio startups of the fund, we may underline Acousia Therapeutics, Fortis Therapeutics, Avelas Biosciences Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Health Care. The fund has exact preference in a number of founders of portfolio startups.

The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2016. The fund is generally included in less than 2 deals every year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Bregua Corporation:
Typical Co-investors
Bregua Corporation is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Bregua Corporation:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
A.T.E. Chandra Foundation India, Maharashtra, Mumbai
Changjianghui Jijin China, Shanghai
DMG Media England, London, United Kingdom
Forec -
Morale Capital Chaoyang, China, Liaoning
Morningstar Japan Chiba Prefecture, Japan, Tateyama
SLO Seed Ventures California, San Luis Obispo, United States
WVV Capital Milwaukee, United States, Wisconsin

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Enlaza Therapeutics

Biopharma
Biotechnology
Health Care
Therapeutics
$100M30 Apr 2024 La Jolla, California, United States

Janux Therapeutics

Biotechnology
Health Diagnostics
Pharmaceutical
Therapeutics
$125M20 Apr 2021 La Jolla, California, United States

Fortis Therapeutics

Biotechnology
Therapeutics
$40M29 Mar 2021 San Diego, California, United States

Janux Therapeutics

Biotechnology
Health Diagnostics
Pharmaceutical
Therapeutics
$56M03 Mar 2021 La Jolla, California, United States

Acousia Therapeutics

Biotechnology
Health Care
Therapeutics
$11M14 May 2018 Baden-Württemberg

Fortis Therapeutics

Biotechnology
Therapeutics
$18M27 Sep 2016 San Diego, California, United States

Avelas Biosciences

Biotechnology
Diagnostic Equipment
Life Science
Real Time
Surgical Devices
$20M18 Aug 2016 San Diego, California, United States
News
Fortis Therapeutics Raises $40M in Series A Funding

– Fortis Therapeutics from San Diego is developing novel antibody-drug conjugate FOR46 for late-stage multiple myeloma and metastatic castration-resistant prostate cancer.
– The company closed a $40m Series A financing cofunded by Avalon Ventures, Bregua Corporation, Lilly Asia Ventures, Osage University Partners, Vivo Capital, the Myeloma Investment Fund, the venture philanthropy fund of the Multiple Myeloma Research Foundation (MMRF), and Fulcrum 2020, LLC.
– The new investment will be used to advance FOR46 in clinical trials for the treatment of relapsed or refractory multiple myeloma and metastatic castration-resistant prostate cancer.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Bregua Corporation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 52M
Peak activity year 2021
Lead investments 0
Follow on index 0.29
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Enlaza Therapeutics

Biopharma
Biotechnology
Health Care
Therapeutics
$100M30 Apr 2024 La Jolla, California, United States

Janux Therapeutics

Biotechnology
Health Diagnostics
Pharmaceutical
Therapeutics
$125M20 Apr 2021 La Jolla, California, United States

Fortis Therapeutics

Biotechnology
Therapeutics
$40M29 Mar 2021 San Diego, California, United States

Janux Therapeutics

Biotechnology
Health Diagnostics
Pharmaceutical
Therapeutics
$56M03 Mar 2021 La Jolla, California, United States

Acousia Therapeutics

Biotechnology
Health Care
Therapeutics
$11M14 May 2018 Baden-Württemberg

Fortis Therapeutics

Biotechnology
Therapeutics
$18M27 Sep 2016 San Diego, California, United States

Avelas Biosciences

Biotechnology
Diagnostic Equipment
Life Science
Real Time
Surgical Devices
$20M18 Aug 2016 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: